TFM-C supresses leukocyte influx in thioglycollate-induced peritonitis. B6 mice recieved 10 μg/g TFM-C, celecoxib or vehicle at two days and one hour before peritoneal injection of thioglycollate. At four hours after thioglycollate injection, peritoneal lavage fluid was collected and the infiltrating cells were counted. Cell numbers are shown from three separate experiments. * P < 0.05, TFM-C-treated versus vehicle-treated group. * P < 0.05, celecoxib-treated versus TFM-C-treated group.
Chiba et al. Arthritis Research & Therapy 2012 14:R9 doi:10.1186/ar3683